The IoT Community Announces Inmarsat as a Platinum-level Corporate Member in its Elite IoT Ecosystem
Del Ashley, Senior Director for Innovation at Inmarsat, appointed to the IoT Community Advisory Board…
Del Ashley, Senior Director for Innovation at Inmarsat, appointed to the IoT Community Advisory Board…
SAN JOSE, Calif.–(BUSINESS WIRE)–Schrocken Inc. announced today that Bernie Prusaczyk has been appointed CEO of…
STRONGSVILLE, Ohio–(BUSINESS WIRE)–Union Home Mortgage (UHM), a high-growth independent mortgage banking company with a world-class…
Enterprise Connect 2023 is Scheduled for March 27-30, 2023 in Orlando, FL SAN FRANCISCO–(BUSINESS WIRE)–Enterprise…
New Request for Ideas, the largest in the Foundation’s history, aims to support innovative ideas…
OmniLife’s integrated communication and clinical workflow management platform has been helping Transplant Centers streamline organ…
Global research publisher and information analytics provider optimises contract lifecycle and reduces contract generation time…
The Liquidware and IGEL sponsored study shows how the rapid migration to work-from-home during COVID-19…
DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022…
-Primary endpoint analysis expected early Q2 2022- -Final data expected Q2 2022- SAN DIEGO, March…
LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical…
JERSEY CITY, N.J., March 24, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat” MIRAMAR, Fla.,…
Validive® Phase 2b/3 VOICE Trial Continues Adding Sites in the U.S. and Europe Camsirubicin Phase…
NEW ORLEANS and LONDON, March 24, 2022 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (Nasdaq: VTGN)…
New interim data from TACTI-002 (Part B) evaluating the combination of efti and pembrolizumab in…
Longeveron management presents live at the Second Euro-Geroscience Conference and at a pre-meeting task force…